Novartis Consumer Health B.V.

Novartis Consumer Health B.V., headquartered in the Netherlands (NL), currently does not report specific carbon emissions data, as no emissions figures are available. However, the company is part of a broader corporate family under Novartis AG, which has established significant climate commitments and initiatives.

As a current subsidiary of Novartis AG, Novartis Consumer Health B.V. inherits its climate targets and initiatives. Novartis AG has set ambitious science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets encompass Scope 1, 2, and 3 emissions, reflecting a comprehensive approach to climate action.

While specific reduction targets for Novartis Consumer Health B.V. are not detailed, the overarching commitments from Novartis AG include participation in initiatives such as the Carbon Disclosure Project (CDP), RE100, and the Race to Zero campaign. These initiatives underscore the company's dedication to achieving net-zero emissions and promoting sustainability within the healthcare sector.

In summary, while Novartis Consumer Health B.V. does not currently report its own emissions data, it aligns with the climate commitments and reduction strategies set forth by its parent company, Novartis AG, demonstrating a commitment to addressing climate change and reducing carbon footprints across its operations.